ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2019

CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.

Alexey M Petrov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.